ArticlePharmaceuticals (Basel, Switzerland)2024
Intermedin Alleviates Diabetic Cardiomyopathy by Up-Regulating CPT-1β through Activation of the Phosphatidyl Inositol 3 Kinase/Protein Kinase B Signaling Pathway.
Jie Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.